Tweets
Infection and Rituximab-linked Immunoglobulin Deficiency
A recent cohort analysis suggests that RTX-induced Ig deficiency was not associated with an increased risk of severe infection in IMID patients.
https://t.co/mcEc0FpdpR https://t.co/S2vAXSWlso
Dr. John Cush @RheumNow ( View Tweet )
6 days 22 hours ago
Case of Delayed Rheum Diagnosis
The Washington Post recently published a case titled, "Medical Mysteries: A rolled ankle set this runner down a painful path", which tells the tale of how/why rheums are often not consulted or consulted too late.
https://t.co/rusIwlELHu https://t.co/5ePDh4aFDY
Dr. John Cush @RheumNow ( View Tweet )
6 days 23 hours ago
929 Sjogrens pts from 2 French cohorts subdivided into 3 Groups:
1. BALS: Hi B-cell activity, low Sxs (Dz activity worsened w/ time)
2. HSA: Hi systemic Dz
3. LSAHS: low systemic Dz, Hi Sxs
Lymphomas in 3-4% BALS & HSA
https://t.co/xI8qjLO8YQ https://t.co/Z2JBuKSUhi
Dr. John Cush @RheumNow ( View Tweet )
1 week ago
French claims data study of Serious infections in 12K #PsA pts Rx w/ biologics (2015-2020) found 367 (3%) w/serious infxn (17/1000Pys). Compared to adalimumab, a signif. lower SIE risk was seen w/ ETN (HR 0.72), & ustekinumab (HR 0.57) https://t.co/oVomnKuYGJ https://t.co/y5DQatFoCa
Dr. John Cush @RheumNow ( View Tweet )
1 week ago
Series of Chronic Cutaneous Lupus responding to anifrolumab. 6 pts (4 DLE, 2 CCLE) betw 37-66 yrs old w/ Dz duration 10.5 yrs, 4 w/ SLE, all refractory to multiple therapies Rx w/ ANIF w/ Skin benefit. 1 developed herpes, 1 had worsening of nephritis https://t.co/XF8uW5xR66 https://t.co/hIJi94uRvr
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 week ago
We're gearing up for Tuesday Night Rheumatology all April long. Register today!
Our first TNR takes place 4/2 at 6:30pm ET and will focus on Success in Rheumatoid Arthritis.
https://t.co/TTMK07Bf7u https://t.co/lSxmfXI4sD
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 week ago
Top 10 Pharma R&D Budgets in 2023
Pharma budgets have undergone significant changes since COVID. This year Merck & Co. has knocked Roche from previous years of leading in R&D budgets and investments.
https://t.co/xx0eKgXaiQ https://t.co/tMrFlatoMk
Dr. John Cush @RheumNow ( View Tweet )
1 week ago
Insights on Postinfectious ME/CFS
JAMA has reviewed a recent Nature paper wherein an NIH led team of multidisciplinary experts performed an inpatient study of postinfectious ME/CFS patients.
https://t.co/3NiJCqZVy0 https://t.co/GAoBW9U1DW
Dr. John Cush @RheumNow ( View Tweet )
1 week 1 day ago
91 #SLE pts w/ no baseline synovitis, underwent Ultrasound exams. 10 yrs later, 31 had clinical progression of arthritis. Pts w/ progression, 75% had baseline subclinical synovitis on US vs without progression 77% did NOT have an abnormal US at baseline https://t.co/MN9wkNgsQV https://t.co/ozgvjFI531
Dr. John Cush @RheumNow ( View Tweet )
1 week 1 day ago
Biden signs executive order on womens health research ($200 million to NIH interdisc. women res), focus on:
- integrate Women’s Health Across Federal Research prgs
- fund Research on Women’s Midlife Health
- double funding Office Womens Health Research
https://t.co/NKtI5iFKeb https://t.co/G5T0YEdEkO
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 week 1 day ago
Ides of March (3.15.2024)
Dr. Jack Cush has advice for Caesar and the superstitious, and covers pregnancy, platelets, dialysis and vaccinations in Lupus.
https://t.co/s87j9fXQNA https://t.co/QNDXweNAvp
Dr. John Cush @RheumNow ( View Tweet )
1 week 1 day ago
4873 gout pts w/ High SUA renally typed: UA overproduct. (ROA 9%); underexcreter (RUE 61%); combined (23%) or normal (7%)
ROL: older, lower SUA, tophi & DM
RUE: lower BMI, No DM
Combined: younger, HighBMI/SUA/eGFR & smoking
Normal: older, Low SUA/eGFR https://t.co/9u0Lujlkqf https://t.co/gVOvwd54Z1
Dr. John Cush @RheumNow ( View Tweet )
1 week 2 days ago